Stocks
Sarepta Therapeutics (SRPT) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -317.4 | -594.9 | -453.7 | 316.9 | -648.0 | 121.6 | ||
| Changes by years, y/y, % | -30% | +87% | -24% | -170% | -304% | +7.4% | |||
Sarepta Therapeutics. EBITDA US GAAP, bln rub
Sarepta Therapeutics. EBITDA US GAAP, changes, %
Sarepta Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Sarepta Therapeutics (SRPT) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -369.0 | 169.7 | -168.0 | -252.2 | 372.1 | 121.6 | |
| Changes by years, y/y, % | -779% | +526% | -445% | -235% | -201% | |||
| Changes by quarters, q/q, % | -298% | -146% | -199% | +50% | -248% | |||
